Market News

Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growth

Biogen CEO Christopher Viehbacher joins 'Squawk on the Street' to discuss their upcoming product pipeline, developments in Alzheimer treatment and medication and more.

Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

Wedbush analyst Laura Chico maintains Sionna Therapeutics (NASDAQ:SION) with a Neutral and raises the price target from $5 to $6.

Top "Magnificent Seven" Picks for Patient Long-Term Investors

Both stocks have been underwhelming recently, but the long-term appeal is strong.

Protecting Retirement With Cash - Building A Brokered CD Ladder

Cash equivalents are now a powerful, multi-functional asset class for retirees, offering near-bond yields with zero volatility and high liquidity. Read the full analysis now.

FinVolution Group - Depositary Receipt Price Target Decreased by 23.39% to $5.68

Amphenol (NYSE:APH) Emerges as a Quality Investing Standout

Amphenol passes the Caviar Cruise quality screen with strong ROIC, EBIT growth, and cash-backed profits. See why APH fits a quality investing strategy.

Sam Altman’s AI Nightmare Splits ETF Trade: Build Vs. Control

Sam Altman’s AI safety warning puts semiconductor and cybersecurity ETFs on opposite sides of Wall Street’s next big trade.

This ETF Should Rise as Interest Rates Go Up. Is It Too Late to Get In on the Fun Now?

The ProShares Equities for Rising Rates ETF has gotten a lift from oil stocks. But the fund’s holdings in tech and financials should help keep the momentum going.

AI Infrastructure Takes A Collective Tumble

There was nowhere to hide in our AI infrastructure basket on Monday, with every stock closing lower.

Barclays Upgrades ZIM Integrated Shipping Services to Equal-Weight from Underweight

Arista Networks (NYSE:ANET): High-Growth Leadership and Momentum in Focus

ANET screens well for CANSLIM growth, profitability, and leadership, but rich valuation and cooling trend demand strict risk controls.

What's Going On With Marvell Technology Stock Tuesday?

Marvell (MRVL) gains 1%+ in premarket after Monday's dip. Check technical levels, RSI, and analyst forecasts for MRVL.

Michael Burry Just Said 7 Words Dismissing AI After Slowdown Fears: "There Is Nothing AI to Slow Down." Should Investors Trust His Nvidia and Palantir Shorts?

Burry made a fortune by shorting the mortgage bond market ahead of the financial crisis.

Special Opportunities Fund: Review Of The Semi-Annual Shareholder Report

Special Opportunities Fund (SPE) H1 2026 update: performance vs. S&P 500, discount to NAV, buybacks/activism, and SPE-C yield-to-maturity. See more here.

Piper Sandler Initiates Coverage of Fidelity National Information Services with Neutral Rating

GigaCloud Technology Inc - A (NASDAQ:GCT) Passes Minervini Trend Template and High Growth Momentum Screen

GCT passes Minervini Trend Template and High Growth Momentum screen, showing Stage 2 uptrend strength plus strong earnings and sales growth.

UBS Maintains Neutral on Center, Lowers Price Target to $68

UBS maintains Center (NYSE:CSR) with a Neutral and lowers the price target from $70 to $68.

WEN, CMG, SBUX, MCD, CAVA Stocks: Seaport Sees One Stock Stand Out Amid Restaurant Traffic Weakness, Valuation Risks

Seaport sees different trends across the restaurant stocks, with CAVA offering strong growth potential, while Wendy’s, Chipotle, Starbucks and McDonald’s face concerns around…